General Info

Established in 1987, Cephalon is a global biopharmaceutical company that is dedicated to the discovery, development and marketing of innovative products designed to treat sleep and neurological disorders, cancer and pain. Employing more than 2,500 people in the United States and Europe, the company maintains its international headquarters in Frazer, Penn., with offices, laboratories and manufacturing facilities in West Chester, Penn., Salt Lake City, Utah and Minneapolis, Minn. Its European headquarters are maintained in Maisons-Alfort, France, with other offices locations in Guildford, England, and Martinsried, Germany. The company markets four proprietary products in the United States, including PROVIGIL, GABITRIL, ACTIQ and TRISENOX, in addition to more than 20 products internationally.